Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 29, 2016
Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing SurgeryGabriela Vojtechova, Lucie Benesova, Barbora Belsanova, et al.Cardiology|January 31, 2015
Variants in miRNA regulating cardiac growth are not a common cause of hypertrophic cardiomyopathyKarol Curila, Lucie Benesova, Pavol Tomasov, et al.Gastroenterology Research and Practice|October 27, 2016
Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric CancersPetra Minarikova, Lucie Benesova, Tereza Halkova, et al.Journal of Thrombosis and Thrombolysis|October 12, 2012
Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery diseasePetra Paulu, Pavel Osmancik, Petr Tousek, et al.Journal of Cancer|January 6, 2023
Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLCMarcela Buresova, Lucie Benesova, Marek Minarik, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 20, 2015
High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.World Journal of Gastroenterology|May 31, 2016
Longitudinal molecular characterization of endoscopic specimens from colorectal lesionsPetra Minarikova, Lucie Benesova, Tereza Halkova, et al.Anticancer Research|January 2, 2016
Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLCOndrej Fiala, Milos Pesek, Jindrich Finek, et al.Cancer Genomics & Proteomics|February 19, 2022
Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective StudyOndrej Fiala, Jan Baxa, Martin Svaton, et al.Anticancer Research|April 30, 2016
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with ErlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.Pageof 5